drugset / Trial / NCT00429494
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
NaSingle-groupOpen-labelTreatment
Summary
Primary Objectives: * To determine the effectiveness of the 3-month depot leuprolide in inducing and maintaining secondary amenorrhea in patients undergo hematopoietic stem cell transplantation. * To determine the incidence of regained ovarian function manifested as spontaneous restoration of menstruation and normalization of hormonal level in patients after transplantation and discontinuation of long-acting leuprolide.
Timeline
- Start
- 2002-11
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leuprolide | Other / unclassified | 22.5 mg | Intramuscular |